Radiolabeled peptides: valuable tools for the detection and treatment of cancer von Fani, M, Maecke, H R, Okarvi, S M

Volltext

Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals? von Antunes, P, Ginj, M, Zhang, H, Waser, B, Baum, R P, Reubi, J C, Maecke, H

Volltext

Yttrium-90 DOTATOC: first clinical results von Otte, A., Herrmann, R., Heppeler, A., Behe, M., Jermann, E., Powell, P., Maecke, H. R., Muller, J.

Volltext

Somatostatin-based radiopeptide therapy with [177Lu-DOTA]-TOC versus [90Y-DOTA]-TOC in neuroendocrine tumours von Romer, A., Seiler, D., Marincek, N., Brunner, P., Koller, M. T., Ng, Q. K. T., Maecke, H. R., Müller-Brand, J., Rochlitz, C., Briel, M., Schindler, C., Walter, M. A.

Volltext

Gastrointestinal neuroendocrine tumors (NETs): new diagnostic and therapeutic challenges von Castaño, J. P., Sundin, A., Maecke, H. R., Villabona, C., Vazquez-Albertino, R., Navarro, E., Öberg, K.

Volltext

Tegaserod, a 5‐HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects von Degen, L., Matzinger, D., Merz, M., Appel‐Dingemanse, S., Osborne, S., Lüchinger, S., Bertold, R., Maecke, H., Beglinger, C.

Volltext

Current status and future perspectives of PSMA-targeted therapy in Europe: opportunity knocks von Pfestroff, A., Luster, M., Jilg, C. A., Olbert, P. J., Ohlmann, C. H., Lassmann, M., Maecke, H. R., Ezziddin, S., Bodei, L.

Volltext

Targeted therapy in nuclear medicine—current status and future prospects von Oyen, W. J. G., Bodei, L., Giammarile, F., Maecke, H. R., Tennvall, J., Luster, M., Brans, B.

Volltext

Indication for Different Mechanisms of Kidney Uptake of Radiolabeled Peptides von Gotthardt, Martin, van Eerd-Vismale, Julliette, Oyen, Wim J.G, de Jong, Marion, Zhang, Hanwen, Rolleman, Edgar, Maecke, Helmut R, Behe, Martin, Boerman, Otto

Volltext

Yttrium-90-labelled somatostatin-analogue for cancer treatment von Otte, A, Mueller-Brand, J, Dellas, S, Nitzsche, EU, Herrmann, R, Maecke, HR

Volltext

DOTATOC: A powerful new tool for receptor-mediated radionuclide therapy von Otte, A., Jermann, E., Behe, M., Goetze, M., Bucher, H. C., Roser, H. W., Heppeler, A., Mueller-Brand, J., Maecke, H. R.

Volltext

Biodistribution of Two Octreotate Analogs Radiolabeled with Indium and Yttrium in Rats von LAZNICKOVA, A, LAZNICEK, M, TREJTNAR, F, MAECKE, H. R, EISENWIENER, K. P, REUBI, J. C

Volltext

Convenient Preparation of 68Ga-Based PET-Radiopharmaceuticals at Room Temperature von Velikyan, I, Maecke, H, Langstrom, B

Volltext

Convenient Preparation of 68 Ga-Based PET-Radiopharmaceuticals at Room Temperature von Velikyan, I., Maecke, H., Langstrom, B.

Volltext

A new cause of renal thrombotic microangiopathy: Yttrium 90-DOTATOC internal radiotherapy von Moll, Solange, Nickeleit, Volker, Mueller-Brand, Jan, Brunner, Felix P., Maecke, Helmut R., Mihatsch, Michael J.

Volltext

Successful Targeted Radiotherapy with Y-DOTATOC in a Patient with Merkel Cell Carcinoma: A Case Report von Meier, G, Waldherr, C, Herrmann, R, Maecke, H, Mueller-Brand, J, Pless, M

Volltext

Pre-therapeutic dosimetry with radiolabelled somatostatin analogues in patients with advanced neuroendocrine tumours von Forrer, F, Mueller-Brand, J, Maecke, H

Volltext

Synthesis and physicochemical characterization of a novel precursor for covalently bound macromolecular MRI contrast agents von André, J P, Maecke, H R, Tóth, E, Merbach, A A

Volltext

Influence of Different Spacers on the Biological Profile of a DOTA−Somatostatin Analogue von Antunes, Patricia, Ginj, Mihaela, Walter, Martin A, Chen, Jianhua, Reubi, Jean-Claude, Maecke, Helmut R

Volltext

Receptor Affinity and Preclinical Biodistribution of Radiolabeled Somatostatin Analogs von LAZNICEK, Milan, LAZNICKOVA, Alice, MAECKE, Helmut R

Volltext